Anthropic Abandons $6B Decart Acquisition | IPO Strategy Explained

Anthropic Ends Talks for Decart Acquisition

Anthropic has officially decided against the acquisition of artificial intelligence startup Decart AI. People familiar with the situation confirmed that the deal, which carried a projected valuation of $6 billion, will not move forward at this time. This decision comes after a period of intense due diligence by the San Francisco-based AI developer.

While the financial specifics of the proposed merger remain private, the breakdown signals a pause in the aggressive consolidation seen among major AI labs during 2026. Anthropic representatives declined to comment on the internal deliberations that led to the termination of the talks. The two companies may still explore less formal partnerships in the future, according to one person with knowledge of the matter.

Internal Strategy and Market Context

This shift in direction arrives as Anthropic prepares for a significant public market debut. Financial records indicate that the company is currently finalizing a $15 billion pre-IPO credit facility to bolster its balance sheet before going public. Revenue projections for the firm have climbed steadily, with some internal estimates placing their annual run rate above $65 billion.

But the path to an initial public offering remains crowded with regulatory and operational challenges. The United States government maintains a restrictive stance regarding certain AI deployments, including a current Pentagon ban on Anthropic software. These external pressures force the leadership team to weigh the benefits of acquiring specialized startups against the risks of increased regulatory scrutiny.

The Larger Picture for AI Consolidation

Acquisitions in the artificial intelligence sector often aim to secure talent or proprietary infrastructure. Decart AI, known for its specific technical focus, represented a potential asset for scaling model efficiency. Yet, for a company the size of Anthropic, the cost of integration often outweighs the immediate technical gains when valuations reach the $6 billion range.

Industry analysts note that high-profile deals have become difficult to finalize as antitrust agencies grow more vigilant. Regulators are now questioning how much control large labs exert over the underlying models used by smaller players. With Anthropic focused on its upcoming IPO, minimizing legal and operational noise is a logical tactical move. Investors will be watching closely to see if other potential acquisitions are shelved as the company shifts its primary energy toward the public market launch.